Emerging treatments for essential thrombocythemia

por Okoli, Steven, Harrison, Claire
Publicado 2011

The Prescribing Skills Assessment: a step towards safer prescribing

por Harrison, Claire, Hilmer, Sarah
Publicado 2019

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?

por McLornan, Donal, Harrison, Claire
Publicado 2013

New versus old blood - the debate continues

por Laurie, John, Wyncoll, Duncan, Harrison, Claire
Publicado 2010

Treatment and management of myelofibrosis in the era of JAK inhibitors

por Keohane, Clodagh, Radia, Deepti H, Harrison, Claire N
Publicado 2013

Ruxolitinib is effective in patients with intermediate-1 risk myelofibrosis: a summary of recent evidence

por Harrison, Claire N., Talpaz, Moshe, Mead, Adam J.
Publicado 2016

Management of myelofibrosis after ruxolitinib failure

por Harrison, Claire N, Schaap, Nicolaas, Mesa, Ruben A
Publicado 2020

Bone marrow niche dysregulation in myeloproliferative neoplasms

por Curto-Garcia, Natalia, Harrison, Claire, McLornan, Donal P
Publicado 2020

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date

por Bassiony, Sarah, Harrison, Claire N, McLornan, Donal P
Publicado 2020

Cortisol reactivity to psychosocial stress is greater in sexual risk takers

por Harrison, Claire, Ratcliffe, Joanne M., Mitchell, Melanie, Smith, Michael A.
Publicado 2014

Physiological Responses and Nutritional Intake during a 7-Day Treadmill Running World Record

por Berger, Nicolas, Cooley, Daniel, Graham, Michael, Harrison, Claire, Best, Russ
Publicado 2020

Consistency Is Key When Setting a New World Record for Running 10 Marathons in 10 Days

por Berger, Nicolas, Cooley, Daniel, Graham, Michael, Harrison, Claire, Campbell, Georgia, Best, Russ
Publicado 2021

Comparative Efficacy of Three Forms of Parenteral Iron

por Dillon, Richard, Momoh, Ibrahim, Francis, Yvonne, Cameron, Laura, Harrison, Claire N., Radia, Deepti
Publicado 2012

PB2185: EFFECT OF NEW OR WORSENING ANEMIA ON CLINICAL OUTCOMES IN PATIENTS WITH MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX): A POST HOC ANALYSIS OF THE COMFORT-I AND -II TRIA...

por Al-Ali, Haifa Kathrin, Mesa, Ruben, Hamer-Maansson, J.E., Braunstein, Evan, Harrison, Claire
Publicado 2023

Changes in Pain and Nutritional Intake Modulate Ultra-Running Performance: A Case Report

por Best, Russ, Barwick, Benjamin, Best, Alice, Berger, Nicolas, Harrison, Claire, Wright, Matthew, Sparrow, Julie
Publicado 2018

Ruxolitinib for the Treatment of Essential Thrombocythemia

por Gunawan, Arief, Harrington, Patrick, Garcia-Curto, Natalia, McLornan, Donal, Radia, Deepti, Harrison, Claire
Publicado 2018

Real-world survival of US patients with intermediate- to high-risk myelofibrosis: impact of ruxolitinib approval

por Verstovsek, Srdan, Parasuraman, Shreekant, Yu, Jingbo, Shah, Anne, Kumar, Shambhavi, Xi, Ann, Harrison, Claire
Publicado 2021

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019

por McLornan, Donal P., Yakoub-Agha, Ibrahim, Robin, Marie, Chalandon, Yves, Harrison, Claire N., Kroger, Nicolaus
Publicado 2019

Characteristics and outcomes of patients with essential thrombocythemia or polycythemia vera diagnosed before 20 years of age: a systematic review

por Ianotto, Jean-Christophe, Curto-Garcia, Natalia, Lauermanova, Marie, Radia, Deepti, Kiladjian, Jean-Jacques, Harrison, Claire N.
Publicado 2019

Efficacy and Safety of Cytoreductive Therapies in Patients with Essential Thrombocythaemia Aged >80 Years: An Interim Analysis of the EXELS Study

por Kiladjian, Jean-Jacques, Besses, Carlos, Griesshammer, Martin, Gugliotta, Luigi, Harrison, Claire, Coll, Ruth, Smith, Jonathan, Birgegård, Gunnar
Publicado 2012